291 related articles for article (PubMed ID: 3035380)
41. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.
Strauss M; Filman DJ; Belnap DM; Cheng N; Noel RT; Hogle JM
J Virol; 2015 Apr; 89(8):4143-57. PubMed ID: 25631086
[TBL] [Abstract][Full Text] [Related]
42. The structure of coxsackievirus B3 at 3.5 A resolution.
Muckelbauer JK; Kremer M; Minor I; Diana G; Dutko FJ; Groarke J; Pevear DC; Rossmann MG
Structure; 1995 Jul; 3(7):653-67. PubMed ID: 8591043
[TBL] [Abstract][Full Text] [Related]
43. The three-dimensional structure of Infectious flacherie virus capsid determined by cryo-electron microscopy.
Xie L; Zhang Q; Lu X; Dai X; Li K; Hong J; Zhou X
Sci China C Life Sci; 2009 Dec; 52(12):1186-91. PubMed ID: 20016976
[TBL] [Abstract][Full Text] [Related]
44. A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly.
Marc D; Girard M; van der Werf S
J Gen Virol; 1991 May; 72 ( Pt 5)():1151-7. PubMed ID: 1851815
[TBL] [Abstract][Full Text] [Related]
45. Acylation of proteins with myristic acid occurs cotranslationally.
Wilcox C; Hu JS; Olson EN
Science; 1987 Nov; 238(4831):1275-8. PubMed ID: 3685978
[TBL] [Abstract][Full Text] [Related]
46. Structural studies of poliovirus mutants that overcome receptor defects.
Wien MW; Curry S; Filman DJ; Hogle JM
Nat Struct Biol; 1997 Aug; 4(8):666-74. PubMed ID: 9253417
[TBL] [Abstract][Full Text] [Related]
47. Novel, structure-based mechanism for uridylylation of the genome-linked peptide (VPg) of picornaviruses.
Schein CH; Volk DE; Oezguen N; Paul A
Proteins; 2006 Jun; 63(4):719-26. PubMed ID: 16498624
[TBL] [Abstract][Full Text] [Related]
48. Iodination of poliovirus capsid proteins.
Beneke TW; Habermehl KO; Diefenthal W; Buchholz M
J Gen Virol; 1977 Feb; 34(2):387-90. PubMed ID: 190350
[No Abstract] [Full Text] [Related]
49. Limits of structural plasticity in a picornavirus capsid revealed by a massively expanded equine rhinitis A virus particle.
Bakker SE; Groppelli E; Pearson AR; Stockley PG; Rowlands DJ; Ranson NA
J Virol; 2014 Jun; 88(11):6093-9. PubMed ID: 24648455
[TBL] [Abstract][Full Text] [Related]
50. Use of the multiple copy simultaneous search (MCSS) method to design a new class of picornavirus capsid binding drugs.
Joseph-McCarthy D; Hogle JM; Karplus M
Proteins; 1997 Sep; 29(1):32-58. PubMed ID: 9294865
[TBL] [Abstract][Full Text] [Related]
51. Formation of poliomyelitis subviral particles in the yeast Saccharomyces cerevisiae.
Jore JP; Veldhuisen G; Kottenhagen M; Pouwels PH; Foriers A; Rombaut B; Boeyé A
Yeast; 1994 Jul; 10(7):907-22. PubMed ID: 7985418
[TBL] [Abstract][Full Text] [Related]
52. Myristylation of gag protein in human T-cell leukemia virus type-I and type-II.
Ootsuyama Y; Shimotohno K; Miwa M; Oroszlan S; Sugimura T
Jpn J Cancer Res; 1985 Dec; 76(12):1132-5. PubMed ID: 3005204
[TBL] [Abstract][Full Text] [Related]
53. Myristoylation of budgerigar fledgling disease virus capsid protein VP2.
Schmidt M; Müller H; Schmidt MF; Rott R
J Virol; 1989 Jan; 63(1):429-31. PubMed ID: 2535744
[TBL] [Abstract][Full Text] [Related]
54. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions.
Duncan G; Pelletier I; Colbère-Garapin F
Virology; 1998 Feb; 241(1):14-29. PubMed ID: 9454713
[TBL] [Abstract][Full Text] [Related]
55. Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group.
Stanway G; Kalkkinen N; Roivainen M; Ghazi F; Khan M; Smyth M; Meurman O; Hyypiä T
J Virol; 1994 Dec; 68(12):8232-8. PubMed ID: 7966616
[TBL] [Abstract][Full Text] [Related]
56. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
Dove AW; Racaniello VR
J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
[TBL] [Abstract][Full Text] [Related]
57. Eclipse products of poliovirus after cold-synchronized infection of HeLa cells.
Everaert L; Vrijsen R; Boeyé A
Virology; 1989 Jul; 171(1):76-82. PubMed ID: 2545039
[TBL] [Abstract][Full Text] [Related]
58. Poliovirus-associated protein kinase: destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn2+.
Ratka M; Lackmann M; Ueckermann C; Karlins U; Koch G
J Virol; 1989 Sep; 63(9):3954-60. PubMed ID: 2548009
[TBL] [Abstract][Full Text] [Related]
59. Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects.
Tsang SK; Danthi P; Chow M; Hogle JM
J Mol Biol; 2000 Feb; 296(2):335-40. PubMed ID: 10669591
[TBL] [Abstract][Full Text] [Related]
60. Method for detection of picornavirus capsid binders with soluble intercellular adhesion molecule 1.
Last-Barney K; Marlin SD; Pal K; Cahill-Feehan C; McNally EJ; Jeanfavre DD; Merluzzi VJ
Antimicrob Agents Chemother; 1993 Aug; 37(8):1693-5. PubMed ID: 8105750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
